Subtype
Extranodal NK-/T-Cell Lymphoma, Nasal Type
CI-CAN-00009487Explore in graph →
Hematologic2 active trials
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00009487Explore in graph →
Clinical trials
23 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (4)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03493451 | Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms | completed | Phase 2 | 77 | BeiGeneINDUSTRY | 5 | Oct 26, 2024 | clinicaltrials |
| NCT02733458 | GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma | completed | N/A | 52 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Sep 14, 2021 | clinicaltrials |
| NCT03079544 | Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL Patients | completed | — | 665 | Rong TaoOTHER | 1 | Sep 14, 2021 | clinicaltrials |
| NCT02764281 | MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell Lymphoma | completed | N/A | 53 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Apr 27, 2020 | clinicaltrials |
| NCT02386813 | International Extranodal NK/T-cell Lymphoma Project(PINK) | completed | — | 770 | Samsung Medical CenterOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT00901147 | Study of Bortezomib and Panobinostat in Treating Patients With Relapsed/Refractory Peripheral T-cell Lymphoma or NK/T-cell Lymphoma | completed | Phase 2 | 25 | Singapore General HospitalOTHER | 3 | Jun 27, 2014 | clinicaltrials |
Data updated 23 days agoSource updated Oct 26, 2024source: clinicaltrials